{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:15Z","timestamp":1790948355482,"version":"4.1.0"},"reference-count":29,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3960\/jslrt.20066","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T22:13:37Z","timestamp":1625004817000},"page":"152-161","source":"Crossref","is-referenced-by-count":8,"title":["Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified"],"prefix":"10.3960","volume":"61","author":[{"given":"Hiroe","family":"Itami","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nakamine","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, The Japan Baptist Hospital, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Takanohara Central Hospital, Nara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"},{"name":"Department of Diagnostic Pathology, Minami-Nara General Medical Centre, Oyodo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Ohbayashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In : Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds) : Who Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC. 2017; pp. 317-318."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ponzoni M, Arrigoni G, Gould VE <i>et al.<\/i> Lack of CD 29 (\u03b21 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000; 31: 220-226.","DOI":"10.1016\/S0046-8177(00)80223-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kinoshita M, Izumoto S, Hashimoto N <i>et al.<\/i> Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas. Brain Tumor Pathol. 2008; 25: 73-78.","DOI":"10.1007\/s10014-008-0232-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Sakakibara A, Inagaki Y, Imaoka E <i>et al.<\/i> Autopsy case report of intravascular large B-cell lymphoma with neoplastic PD-L1 expression. J Clin Exp Hematop. 2018; 58: 32-35.","DOI":"10.3960\/jslrt.17037"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kiyasu J, Miyoshi H, Hirata A <i>et al.<\/i> Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015; 126: 2193-2201.","DOI":"10.1182\/blood-2015-02-629600"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Gupta GK, Jaffe ES, Pittaluga S. A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features. Histopathology. 2019; 75: 282-286.","DOI":"10.1111\/his.13870"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sakakibara A, Inagaki Y, Imaoka E <i>et al.<\/i> Divergence and heterogeneity of neoplastic PD-L1 expression: two autopsy case reports of intravascular large B-cell lymphoma. Pathol Int. 2019; 69: 148-154.","DOI":"10.1111\/pin.12757"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Suzuki Y, Sakakibara A, Shimada K <i>et al.<\/i> Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma. Pathol Int. 2019; 69: 13-20.","DOI":"10.1111\/pin.12742"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Suzuki Y, Kohno K, Matsue K <i>et al.<\/i> PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy. Cancer Med. 2020; 9: 4768-4776.","DOI":"10.1002\/cam4.3104"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Imai H, Kajimoto K, Taniwaki M <i>et al.<\/i> Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: A report of five cases. Pathol Int. 2004; 54: 231-236.","DOI":"10.1111\/j.1440-1827.2004.01613.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Thomas CA, Guileyardo JM, Krause JR. An intravascular lymphoma with extravascular tendencies. Proc Bayl Univ Med Cent. 2014; 27: 341-343.","DOI":"10.1080\/08998280.2014.11929153"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Uchiyama T, Nakamine H, Morita K <i>et al.<\/i> Intravascular large B-cell lymphoma coexisting with an ovarian carcinoma. J Clin Exp Hematop. 2016; 56: 59-63.","DOI":"10.3960\/jslrt.56.59"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Poropatich K, Dittmann D, Chen YH <i>et al.<\/i> A small case series of intravascular large B-cell lymphoma with unexpected findings: subset of cases with concomitant extravascular central nervous system (CNS) involvement mimicking primary CNS lymphoma. J Pathol Transl Med. 2017; 51: 284-291.","DOI":"10.4132\/jptm.2017.02.16"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Abe Y, Usui Y, Narita K, Takeuchi M, Matsue K. Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity? Int J Hematol. 2018; 108: 637-639.","DOI":"10.1007\/s12185-018-2532-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Matsue K, Abe Y, Narita K <i>et al.<\/i> Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years. Br J Haematol. 2019; 187: 328-336.","DOI":"10.1111\/bjh.16081"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Murase T, Yamaguchi M, Suzuki R <i>et al.<\/i> Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007; 109: 478-485.","DOI":"10.1182\/blood-2006-01-021253"},{"key":"17","unstructured":"17 Gatter KC, Warnke RA. Intravascular large B-cell lymphoma. In : Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) : World Health Organization: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC. 2001; pp. 177-178."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Kano R, Masaie H, Hino A <i>et al.<\/i> Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities. Diagn Pathol. 2018; 13: 46.","DOI":"10.1186\/s13000-018-0724-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kasuya A, Hashizume H, Takigawa M. Early diagnosis of recurrent diffuse large B-cell lymphoma showing intravascular lymphoma by random skin biopsy. J Dermatol. 2011; 38: 571-574.","DOI":"10.1111\/j.1346-8138.2010.01127.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Zhao XF, Sands AM, Ostrow PT <i>et al.<\/i> Recurrence of nodal diffuse large B-cell lymphoma as intravascular large B-cell lymphoma: is an intravascular component at initial diagnosis predictive? Arch Pathol Lab Med. 2005; 129: 391-394.","DOI":"10.5858\/2005-129-391-RONDLB"},{"key":"21","unstructured":"21 Katz DA, Miller IJ, Gregory SA. Intravascular B-cell lymphoma following nodal diffuse large B-cell lymphoma. Clin Adv Hematol Oncol. 2010; 8: 637-641."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Jain P, Fayad LE, Rosenwald A, Young KH, O\u2019Brien S. Recent advances in de novo CD5 + diffuse large B cell lymphoma. Am J Hematol. 2013; 88: 798-802.","DOI":"10.1002\/ajh.23467"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Na HY, Choe JY, Shin SA <i>et al.<\/i> Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: high incidence of BCL2 and MYC double-expressors. PLoS One. 2019; 14: e0224247.","DOI":"10.1371\/journal.pone.0224247"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Yamaguchi M, Seto M, Okamoto M <i>et al.<\/i> De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002; 99: 815-821.","DOI":"10.1182\/blood.V99.3.815"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Huang S, Nong L, Liang L <i>et al.<\/i> Comparison of PD-L1 detection assays and corresponding significance in evaluation of diffuse large B-cell lymphoma. Cancer Med. 2019; 8: 3831-3845.","DOI":"10.1002\/cam4.2316"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Chen BJ, Dashnamoorthy R, Galera P <i>et al.<\/i> The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma. Oncotarget. 2019; 10: 2030-2040.","DOI":"10.18632\/oncotarget.26771"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Fang X, Xiu B, Yang Z <i>et al.<\/i> The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma. Medicine (Baltimore). 2017; 96: e6398.","DOI":"10.1097\/MD.0000000000006398"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kwon D, Kim S, Kim PJ <i>et al.<\/i> Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas. Histopathology. 2016; 68: 1079-1089.","DOI":"10.1111\/his.12882"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Menter T, Bodmer-Haecki A, Dirnhofer S, Tzankov A. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Hum Pathol. 2016; 54: 17-24.","DOI":"10.1016\/j.humpath.2016.03.005"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/3\/61_20066\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:25:02Z","timestamp":1715145902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/3\/61_20066\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20066","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"20066"}}